Interleukin 2 therapy for disseminated cancer.
D004341:Drug Evaluation; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects / Q000627:therapeutic use*; D007694:Killer Cells, Natural; D008222:Lymphokines; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2; D008222:Lymphokines